Medco Says Cancer-Drug Spending May Climb 42% by 2013

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

May 18 (Bloomberg) -- Spending on cancer drugs by U.S. employers and health insurers may climb as much as 42 percent by the end of 2013 as the number of patients rises and new medicines reach the market, according to Medco Health Solutions Inc. Shannon Pettypiece reports in Bloomberg Television's "InBusiness with Margaret Brennan." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change